Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Hydroxyurea-containing salvage regimens for advanced-stage HIV infection

Dec. 2, 1998

Clinical anti-HIV activity of FTC correlated with intracellular levels of triphosphate

Dec. 2, 1998

FDA informs Ligand that Panretin Gel is approvable

Dec. 1, 1998

First patient treated in phase II HIV gene therapy study

Dec. 1, 1998

More on the contraceptive effects, anti-HIV activity of WHI compounds

Nov. 27, 1998

Novel agents for HIV: protease inhibitor/reverse transcriptase inhibitor conjugates

Nov. 27, 1998

New treatment option for pediatric HIV/AIDS now available in U.S.

Nov. 27, 1998

HIV integrase inhibitors under study at CNRS

Nov. 25, 1998

Caution recommended with zidovudine/lamivudine combination: observations of anemia reported

Nov. 25, 1998

Unimed returns nitazoxanide rights to Romark

Nov. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...